Literature DB >> 6830619

Intestinal metabolism of tyramine by both forms of monoamine oxidase in the rat.

M S Benedetti, T Boucher, A Carlsson, C J Fowler.   

Abstract

The two forms of monoamine oxidase (MAO) in rat intestine and brain homogenates were found to have different Km and Vmax values towards tyramine. The Km values for the A-form of the enzyme towards this substrate were around 120 microM in both cases, whereas the values for the B-form were about 240 microM. As a consequence, the ratio of activities (MAO-A: MAO-B) towards tyramine are dependent upon the substrate concentration. The MAO-A-selective inhibitors, toloxatone and cimoxatone, were found to be competitive inhibitors of the oxidation of tyramine by the A-form of this enzyme in the rat intestine, with Ki values of 3.4 microM and 3.7 nM respectively. The significance of these results in relation to the "cheese effect", a pressor response to tyramine after monoamine oxidase inhibition, are discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6830619     DOI: 10.1016/0006-2952(83)90650-0

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  6 in total

Review 1.  Monoamine oxidase inhibitors revisited.

Authors:  D G Wells; A R Bjorksten
Journal:  Can J Anaesth       Date:  1989-01       Impact factor: 5.063

2.  The deamination of noradrenaline and 5-hydroxytryptamine by rat brain and heart monoamine oxidase and their inhibition by cimoxatone, toloxatone and MD 770222.

Authors:  M Strolin Benedetti; T Boucher; C J Fowler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-08       Impact factor: 3.000

3.  Effects of ageing on the content in sulfur-containing amino acids in rat brain.

Authors:  M S Benedetti; A Russo; P Marrari; P Dostert
Journal:  J Neural Transm Gen Sect       Date:  1991

4.  Monoamine oxidase inhibitors and the cheese effect.

Authors:  M C Anderson; F Hasan; J M McCrodden; K F Tipton
Journal:  Neurochem Res       Date:  1993-11       Impact factor: 3.996

5.  Inhibition of monoamine oxidase and semicarbazide-sensitive amine oxidase by mexiletine and related compounds.

Authors:  M Eriksson; C J Fowler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-10       Impact factor: 3.000

6.  Selective inhibition by amiflamine of monoamine oxidase type A in rat brain, liver and duodenum.

Authors:  A L Ask
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-08       Impact factor: 3.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.